SPECIAL TOPIC
Heterocyclic Inputs for Povarov MCR
2243
flash chromatography to afford pure 6d as a pale yellow powder.
Yield: 153 mg (35%).
6.66 (d, J = 8.2 Hz, 1 H), 6.01 (br s, 1 H), 5.01 (d, J = 7.0 Hz, 1 H),
4.78–4.73 (m, 1 H), 4.67–4.61 (m, 1 H), 2.19 (s, 3 H).
IR (KBr): 3428, 3333, 3071, 3026, 2923, 2832, 1719, 1508, 1431,
1322, 1258, 1117, 1066, 1014 cm–1.
13C NMR (100 MHz, DMSO-d6): d = 171.9, 142.2, 140.2, 132.3,
128.9, 128.5, 128.4, 128.3, 126.4, 120.9, 115.4, 55.1, 53.9, 53.7,
20.3.
HRMS (ESI+): m/z calcd for C17H16ClN2OS (M + H+): 331.0666;
found: 331.067.
1H NMR (400 MHz, DMSO-d6): d = 7.80 (d, J = 8.2 Hz, 2 H), 7.72
(d, J = 8.1 Hz, 2 H), 7.34 (t, J = 7.3 Hz, 2 H), 7.27 (t, J = 7.2 Hz, 1
H), 7.20 (d, J = 7.2 Hz, 2 H), 6.88 (d, J = 8.7 Hz, 1 H), 6.76 (dd,
J = 8.7, 2.7 Hz, 1 H), 6.55 (d, J = 2.6 Hz, 1 H), 5.80 (s, 1 H), 5.23–
5.13 (m, 1 H), 4.85 (d, J = 9.3 Hz, 1 H), 4.56 (d, J = 16.3 Hz, 1 H),
4.29–4.23 (m, 1 H), 3.92 (d, J = 16.2 Hz, 1 H), 3.63 (s, 3 H).
(3aRS,4RS,9bRS)-4-(Furan-2-yl)-8-methyl-1,4,5,9b-tetrahy-
drothiazolo[5,4-c]quinolin-2(3aH)-one (6g¢)
Following the general procedure A, method C (3 cycles of 10 min),
the reaction of 1c, p-toluidine, and 2-furaldehyde afforded com-
pounds 6g/6g¢ (48%, 6g/6g¢, 1:2). This mixture was purified by
flash chromatography to afford pure 6g¢ as a brown powder. Yield:
67 mg (32%).
13C NMR (100 MHz, DMSO-d6): d = 156.7, 152.2, 152.1, 143.3,
142.3, 142.2, 136.2, 128.9, 128.5, 128.2 (q, J = 31.7 Hz), 127.2,
126.9, 124.9 (q, J = 3.7 Hz), 124.3 (q, J = 272.1 Hz), 119.8, 117.5,
117.5, 115.4, 114.4, 77.3, 77.3, 60.3, 60.2, 55.3, 54.2, 44.7.
HRMS (ESI+): m/z calcd for C25H22F3N2O3 (M + H+): 455.1577;
found: 455.1574.
IR (KBr): 3429, 3135, 3096, 2962, 2924, 1668, 1585, 1553, 1502,
1457, 1367, 1265, 1175, 1028, 899, 816, 733 cm–1.
Ethyl (3aRS,4SR,9bRS)-8-Methyl-2-oxo-1,2,3a,4,5,9b-hexahy-
drothiazolo[5,4-c]quinoline-4-carboxylate (6e)
Following the general procedure A, method C (1 cycle of 10 min),
the reaction of 1c, p-toluidine, and ethyl glyoxalate afforded com-
pounds 6e/6e¢ (72%, 6e/6e¢, 2:1). This mixture was purified by flash
chromatography to afford pure 6e as a pale yellow powder. Yield:
100 mg (48%).
1H NMR (400 MHz, CD3OD): d = 7.51–7.47 (m, 1 H), 7.02–6.98
(m, 1 H), 6.91 (dd, J = 8.2, 1.8 Hz, 1 H), 6.68 (d, J = 8.2 Hz, 1 H),
6.43–6.38 (m, 2 H), 5.09 (d, J = 7.3 Hz, 1 H), 4.87 (d, J = 2.5 Hz, 1
H), 4.79 (d, J = 2.4 Hz, 1 H), 2.23 (s, 3 H).
13C NMR (100 MHz, CD3OD): d = 177.0, 154.9, 143.5, 142.9,
130.2, 130.0, 129.8, 122.6, 117.1, 111.4, 107.6, 55.5, 52.9, 52.7,
20.7.
IR (film): 3334, 3193, 3077, 2917, 2866, 1732, 1694, 1662, 1508,
1329, 1245, 1015, 816 cm–1.
HRMS (ESI+): m/z calcd for C15H15N2O2S (M + H+): 287.0849;
found: 287.0849.
1H NMR (400 MHz, CDCl3): d = 6.99 (dd, J = 8.2, 1.7 Hz, 1 H),
6.92–6.89 (m, 1 H), 6.64 (d, J = 8.2 Hz, 1 H), 5.96 (br s, 1 H), 4.98
(d, J = 6.2 Hz, 1 H), 4.40 (br s, 1 H), 4.29 (q, J = 7.1 Hz, 2 H), 4.10
(d, J = 10.1 Hz, 1 H), 3.95 (ddd, J = 10.1, 6.2, 0.5 Hz, 1 H), 2.25 (s,
3 H), 1.34 (t, J = 7.1 Hz, 3 H).
13C NMR (100 MHz, CDCl3): d = 172.5, 170.0, 140.4, 130.7, 129.8,
129.2, 117.4, 116.2, 62.4, 56.7, 54.1, 45.5, 20.6, 14.3.
(3aRS,4RS,9bSR)-8-Methyl-4-[4-(trifluoromethyl)phenyl]-
1,4,5,9b-tetrahydrothiazolo[5,4-c]quinolin-2(3aH)-one (6h)
Following the general procedure A, method B (5 d), the reaction of
1c, p-toluidine, and 4-(trifluoromethyl)benzaldehyde afforded com-
pounds 6h/6h¢ (55%, 6h/6h¢, 2:1). This mixture was purified by
flash chromatography to afford pure 6h as a yellow powder. Yield:
92 mg (37%).
HRMS (ESI+): m/z calcd for C14H17N2O3S (M + H+): 293.0954;
found: 293.0953.
IR (KBr): 3397, 3186, 3071, 2917, 2879, 1706, 1617, 1508, 1322,
1258, 1168, 1130, 1066, 1002, 829 cm–1.
(3aRS,4RS,9bSR)-4-(4-Chlorophenyl)-8-methyl-1,4,5,9b-tet-
rahydrothiazolo[5,4-c]quinolin-2(3aH)-one (6f)
Following the general procedure A, method B (5 d), the reaction of
1c, p-toluidine, and 4-chlorobenzaldehyde afforded compounds 6f/
6f¢ (44%, 6f/6f¢, 1:2). This mixture was purified by flash chromatog-
raphy to afford pure 6f as a yellow powder. Yield: 64 mg (15%).
1H NMR (400 MHz, DMSO-d6): d = 8.63 (br s, 1 H), 7.76 (d, J = 8.3
Hz, 2 H), 7.71 (d, J = 8.3 Hz, 2 H), 7.03–7.07 (m, 1 H), 6.91 (dd,
J = 8.2, 1.7 Hz, 1 H), 6.65 (d, J = 8.2 Hz, 1 H), 6.33 (s, J = 14.9 Hz,
1H ), 4.94 (d, J = 6.0 Hz, 1 H), 4.23 (d, J = 10.4 Hz, 1 H), 4.00 (dd,
J = 10.4, 6.0 Hz, 1 H), 2.19 (s, 3 H).
13C NMR (100 MHz, DMSO-d6): d = 170.4, 145.5, 142.9, 130.8,
129.7, 129.4, 128.7 (d, J = 31.7 Hz), 125.4, 125.1 (d, J = 3.6 Hz),
124.2 (d, J = 272.0 Hz), 117.0, 114.9, 57.7, 54.6, 49.9, 20.2.
IR (KBr): 3385, 3161, 3071, 2911, 1668, 1617, 1501, 1476, 1341,
1258, 1194, 1085, 1008, 835 cm–1.
1H NMR (400 MHz, DMSO-d6): d = 8.59 (br s, 1 H), 7.52–7.42 (m,
4 H), 7.05–7.02 (m, 1 H), 6.89 (dd, J = 8.3, 1.8 Hz, 1 H), 6.64 (d,
J = 8.2 Hz, 1 H), 6.25 (br s, 1 H), 4.92 (d, J = 6.1 Hz, 1 H), 4.12 (d,
J = 10.5 Hz, 1 H), 3.92 (dd, J = 10.4, 6.0 Hz, 1 H), 2.18 (s, 3 H).
13C NMR (100 MHz, DMSO-d6): d = 170.5, 143.0, 139.8, 132.6,
130.7, 130.6, 129.3, 128.2, 125.3, 117.0, 114.95, 57.4, 54.6, 50.1,
20.2.
HRMS (ESI+): m/z calcd for C18H16F3N2OS (M + H+): 365.093;
found: 365.0929.
(3aRS,4RS,9bSR)-1-Benzyl-8-methyl-4-[4-(trifluorometh-
yl)phenyl]-1,4,5,9b-tetrahydrooxazolo[5,4-c]quinolin-2(3aH)-
one (6j)
Following the general procedure A, method C (1 cycle of 10 min),
the reaction of 1d, p-toluidine, and 4-(trifluoromethyl)benzalde-
hyde afforded compounds 6j/6j¢ as a diastereomeric mixture (75
mg, overall yield 84%, 6j/6j¢, 2:1). This mixture could not be sepa-
rated and was directly oxidized to quinoline 11g following proce-
dure B (see below).
1H NMR (400 MHz, CDCl3): d (diagnostic signals from the mix-
ture) = 7.64 (d, J = 8.2 Hz, 2 H), 7.55 (d, J = 8.2 Hz, 2 H), 7.43–7.27
(m, 5 H), 6.99 (dd, J = 8.0, 1.5 Hz, 1 H), 6.94 (br s, 1 H), 6.66 (d,
J = 8.0 Hz, 1 H), 5.20 (d, J = 15.6 Hz, 1 H), 4.95 (d, J = 8.1 Hz, 1
H), 4.59 (d, J = 3.1 Hz, 1 H), 4.44 (dd, J = 8.1, 3.1 Hz, 1 H), 4.06
(d, J = 15.6 Hz, 1 H), 2.27 (s, 3 H).
HRMS (ESI+): m/z calcd for C17H16ClN2OS (M + H+): 331.0666;
found: 331.0669.
(3aRS,4SR,9bSR)-4-(4-Chlorophenyl)-8-methyl-1,4,5,9b-tet-
rahydrothiazolo[5,4-c]quinolin-2(3aH)-one (6f¢)
In the above process, on further elution, compound 6f¢ was obtained
as a yellow powder. Yield: 125 mg (29%).
IR (KBr): 3385, 3160, 3071, 2911, 1617, 1476, 1341, 1258, 1194,
1085, 1008, 835, 669 cm–1.
1H NMR (400 MHz, DMSO-d6): d = 8.76 (d, J = 1.3 Hz, 1 H), 7.52–
7.43 (m, 4 H), 7.06–7.02 (m, 1 H), 6.86 (dd, J = 8.2, 1.4 Hz, 1 H),
Synthesis 2011, No. 14, 2237–2246 © Thieme Stuttgart · New York